Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Phospho-EphB1/EphB2 (Tyr594, Tyr604) Polyclonal Antibody, Invitrogen™
Rabbit Polyclonal Antibody
Supplier: Thermo Scientific PA538480
Description
Ephrin receptors and their ligands, the ephrins, mediate numerous developmental processes, particularly in the nervous system. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B class, which are transmembrane proteins. The Eph family of receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. Ephrin receptors make up the largest subgroup of the receptor tyrosine kinase family. The protein encoded by this gene is a receptor for ephrin-B family members.
Specifications
Phospho-EphB1/EphB2 (Tyr594, Tyr604) | |
Polyclonal | |
Unconjugated | |
EPHB1 | |
ELK, NET, Hek6, EPHT2, FLJ37986, EPHB1, DRT; ERK; CAPB; Hek5; PCBC; EPHT3; Tyro5; MGC87492; EPHB2, Ephrin type-B receptor 2, Ephrin type-B receptor 1, EphrinB2, Ephrin B2, EphrinB1, Ephrin B1 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
13844, 2047, 2048, 24338, 270190, 313633 | |
-20°C | |
Liquid |
Immunocytochemistry, Immunofluorescence, Western Blot | |
1 mg/mL | |
Dulbecco′s PBS with 150mM NaCl, 50% glycerol and 0.02% sodium azide; pH 7.4 | |
P29323, P54762, P54763, Q8CBF3, P09759 | |
EPHB1, EPHB2 | |
A synthetic phosphopeptide derived from human EPHB1/2 around the phosphorylation site of Tyr594/604 (K-I-YP-I-D) | |
100 μg | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction